Glanzmann's thrombasthenia

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD medical weight loss NYC and sleep center NYC

Glanzmann's thrombasthenia
Synonyms	N/A
Pronounce	N/A
Specialty	N/A
Symptoms	Prolonged bleeding, easy bruising, nosebleeds, gum bleeding, menorrhagia
Complications	Anemia, iron deficiency, hemorrhage
Onset	Birth
Duration	Lifelong
Types	N/A
Causes	Genetic mutation in the ITGA2B or ITGB3 genes
Risks	Family history of the condition
Diagnosis	Platelet aggregation test, flow cytometry, genetic testing
Differential diagnosis	Bernard-Soulier syndrome, von Willebrand disease, immune thrombocytopenic purpura
Prevention	N/A
Treatment	Platelet transfusion, recombinant factor VIIa, antifibrinolytics, bone marrow transplant
Medication	N/A
Prognosis	Variable, depends on severity and management
Frequency	Rare
Deaths	Rare, if managed properly

Glanzmann's thrombasthenia is a rare, inherited bleeding disorder that results from a defect in platelet function. It is characterized by the inability of platelets to properly stick together and form clots to stop bleeding.

Symptoms

The most common symptoms of Glanzmann's thrombasthenia include nosebleeds, bruising, menorrhagia (heavy menstrual bleeding), and gum bleeding. In severe cases, patients may experience gastrointestinal bleeding, hematuria (blood in urine), and intracranial hemorrhage (bleeding in the brain).

Causes

Glanzmann's thrombasthenia is caused by mutations in the ITGA2B and ITGB3 genes. These genes provide instructions for making proteins that play a crucial role in platelet aggregation, a process necessary for normal blood clotting.

Diagnosis

Diagnosis of Glanzmann's thrombasthenia is based on clinical symptoms, family history, and specialized blood tests. These tests may include platelet aggregation tests, flow cytometry, and genetic testing.

Treatment

Treatment for Glanzmann's thrombasthenia is aimed at controlling bleeding episodes and preventing bleeding during surgical procedures. This may involve platelet transfusions, antifibrinolytic medicines, and recombinant factor VIIa.

See also

• Bleeding disorder
• Platelet function disorder
• ITGA2B
• ITGB3

References

This article is a medical stub. You can help WikiMD by expanding it!
Most recent articles Ongoing trials	Wikipedia